Selected
Type of publications
Regions
Countries
Diseases
Methodological quality (AMSTAR 2)
7 results found
2023 ∙ Liu, Y. Kuang, K.
Predictors of COVID-19 vaccination hesitancy in China: a meta-analysis
  • All age groups
  • China
  • COVID-19
  • Acceptance
Rating:
Not applicable
2022 ∙ Xu, B. Zhu, Y.
A systematic review and meta-analysis of the factors associating the willingness of Chinese community residents to receive COVID-19 vaccine
  • All age groups
  • China
  • COVID-19
  • Acceptance
Rating:
Not applicable
2022 ∙ Ma, Y. Ren, J. Zheng, Y. Cai, D. Li, S. Li, Y.
Chinese parents' willingness to vaccinate their children against COVID-19: A systematic review and meta-analysis
  • Parents/caregivers
  • Children
  • Adolescents
  • Adults
  • China
  • COVID-19
  • Acceptance
Rating:
Not applicable
2022 ∙ Shui, X. Wang, F. Li, L. Liang, Q.
COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis
  • Adults
  • Healthcare workers
  • China
  • COVID-19
  • Acceptance
Rating:
Not applicable
2022 ∙ Fu, Y. Zhao, J. Wei, X. Han, P. Yang, L. Ren, T. Zhan, S. Li, L.
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
  • Adults
  • Children
  • Older adults
  • China
  • COVID-19
  • Efficacy/effectiveness
  • Economic aspects
Rating:
Critically low
2022 ∙ Chen, H. Zhang, X. Lin, G. Gong, F. Hocher, B.
Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review
  • Adults
  • China
  • COVID-19
  • Safety
Rating:
Critically low
2021 ∙ Li, W. Liu, S. Qian, S. Zhu, J. Selvaraj, J. N. Zhang, X.
Is the rate of adverse reaction to rabies vaccine in China really as the public thinks?—based on a meta analysis
  • All age groups
  • China
  • Rabies
  • Safety
Rating:
Critically low